Ability of Older People with Dementia or Cognitive Impairment to Manage Medicine Regimens: A Narrative Review

被引:72
|
作者
Elliott, Rohan A. [1 ,2 ]
Goeman, Dianne [3 ,4 ]
Beanland, Christine [3 ]
Koch, Susan [3 ,5 ]
机构
[1] Austin Hlth, Heidelberg Repatriat Hosp, Dept Pharm, Heidelberg, Vic, Australia
[2] Monash Univ, Fac Pharm & Pharmaceut Sci, Ctr Med Use & Safety, Parkville, Vic, Australia
[3] RDNS Inst, St Kilda, Vic, Australia
[4] Monash Univ, Dept Med, Cent Clin Sch, Prahran, Vic, Australia
[5] La Trobe Univ, Sch Nursing, Bundoora, Vic, Australia
来源
CURRENT CLINICAL PHARMACOLOGY | 2015年 / 10卷 / 03期
关键词
Cognitive impairment; dementia; functional ability; medicines management; self-care;
D O I
10.2174/1574884710666150812141525
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Impaired cognition has a significant impact on a person's ability to manage their medicines. The aim of this paper is to provide a narrative review of contemporary literature on medicines management by people with dementia or cognitive impairment living in the community, methods for assessing their capacity to safely manage medicines, and strategies for supporting independent medicines management. Studies and reviews addressing medicines management by people with dementia or cognitive impairment published between 2003 and 2013 were identified via searches of Medline and other databases. The literature indicates that as cognitive impairment progresses, the ability to plan, organise, and execute medicine management tasks is impaired, leading to increased risk of unintentional non-adherence, medication errors, preventable medication-related hospital admissions and dependence on family carers or community nursing services to assist with medicines management. Impaired functional capacity may not be detected by health professionals in routine clinical encounters. Assessment of patients' (or carers') ability to safely manage medicines is not undertaken routinely, and when it is there is variability in the methods used. Self-report and informant report may be helpful, but can be unreliable or prone to bias. Measures of cognitive function are useful, but may lack sensitivity and specificity. Direct observation, using a structured, standardised performance-based tool, may help to determine whether a person is able to manage their medicines and identify barriers to adherence such as inability to open medicine packaging. A range of strategies have been used to support independent medicines management in people with cognitive impairment, but there is little high-quality research underpinning these strategies. Further studies are needed to develop and evaluate approaches to facilitate safe medicines management by older people with cognitive impairment and their carers.
引用
收藏
页码:213 / 221
页数:9
相关论文
共 50 条
  • [41] Single screening questions for cognitive impairment in older people: a systematic review
    Hendry, Kirsty
    Hill, Eilidh
    Quinn, Terry J.
    Evans, Jonathan
    Stott, David J.
    [J]. AGE AND AGEING, 2015, 44 (02) : 322 - 326
  • [42] SINGLE SCREENING QUESTIONS FOR COGNITIVE IMPAIRMENT IN OLDER PEOPLE; A SYSTEMATIC REVIEW
    Hendry, K.
    Hill, E.
    Quinn, T. J.
    Evans, J.
    Stott, D. J.
    [J]. AGE AND AGEING, 2014, 43
  • [43] Contributions of loneliness to cognitive impairment and dementia in older adults are independent of other risk factors and Alzheimer's pathology: a narrative review
    Oken, Barry S.
    Kaplan, Josh
    Klee, Daniel
    Gallegos, Autumn M.
    [J]. FRONTIERS IN HUMAN NEUROSCIENCE, 2024, 18
  • [44] Cognitive interventions in healthy older adults and people with mild cognitive impairment: A systematic review
    Reijnders, Jennifer
    van Heugten, Caroline
    van Boxtel, Martin
    [J]. AGEING RESEARCH REVIEWS, 2013, 12 (01) : 263 - 275
  • [45] Caregivers of People With Mild Cognitive Impairment and Dementia
    Meyer, Oanh L.
    Zheng, Shichen
    Alto, Raquel
    Tran, Duyen
    Luu, San
    Vu, Uyen
    Hinton, Ladson
    Harvey, Danielle
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2024, 38 (01): : 51 - 58
  • [46] Biomarkers for cognitive impairment and dementia in elderly people
    Sonnen, Joshua A.
    Montine, Kathleen S.
    Quinn, Joseph F.
    Kaye, Jeffrey A.
    Breitner, John C. S.
    Montine, Thomas J.
    [J]. LANCET NEUROLOGY, 2008, 7 (08): : 704 - 714
  • [47] Technologies for Cognitive Training and Cognitive Rehabilitation for People With Mild Cognitive Impairment and Dementia. A Systematic Review
    Irazoki, Eider
    Contreras-Somoza, Leslie Maria
    Toribio-Guzman, Jose Miguel
    Jenaro-Rio, Cristina
    van der Roest, Henriette
    Franco-Martin, Manuel A.
    [J]. FRONTIERS IN PSYCHOLOGY, 2020, 11
  • [48] Medication Management for People with Dementia or Cognitive Impairment
    Bell, J. Simon
    Kurrle, Susan
    Hilmer, Sarah N.
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2015, 10 (03): : 166 - +
  • [49] A Review of Self-Management Interventions for People With Dementia and Mild Cognitive Impairment
    Quinn, Catherine
    Toms, Gill
    Anderson, Daniel
    Clare, Linda
    [J]. JOURNAL OF APPLIED GERONTOLOGY, 2016, 35 (11) : 1154 - 1188
  • [50] A systematic review of the health effects of yoga for people with mild cognitive impairment and dementia
    Diana Karamacoska
    Tiffany Tan
    Danielle C. Mathersul
    Angelo Sabag
    Michael de Manincor
    Dennis Chang
    Genevieve Z. Steiner-Lim
    [J]. BMC Geriatrics, 23